Matthew Cooper
Listed on 9 Form D filings across 8+ issuers
· Director, Executive Officer
Associated issuers
- Enumera Molecular, Inc. CIK 1929085 · MI
- Allotera Therapeutics, Inc. CIK 1874298 · MO
- Polis Strategies Fund LLC - Series 1 CIK 2114907 · DE
- Polis MedTech Ventures LLC - Series 3 CIK 2096102 · DE
- Polis MedTech Ventures LLC - Series 4 CIK 2096086 · DE
- Polis MedTech Ventures LLC - Series 1 CIK 2069176 · DE
- Polis MedTech Ventures LLC - Series 2 CIK 2069124 · DE
- Concierge Pediatrics Holdings, LLC CIK 1996374 · NY
Filings (9)
-
Enumera Molecular, Inc.D · Jul 31, 2026 · MI · Other Health Care$17.4MView filing →
-
Allotera Therapeutics, Inc.D · Jul 23, 2026 · MO · Other Health Care$163MView filing →
-
Polis Strategies Fund LLC - Series 1D · Mar 2, 2026 · DE · Pooled Investment Fund$1.9MView filing →
-
Polis MedTech Ventures LLC - Series 3D · Nov 10, 2025 · DE · Pooled Investment Fund$2.5MView filing →
-
Polis MedTech Ventures LLC - Series 4D · Nov 10, 2025 · DE · Pooled Investment Fund$900KView filing →
-
Allotera Therapeutics, Inc.D · Sep 8, 2025 · MO · Other Health Care$163MView filing →
-
Polis MedTech Ventures LLC - Series 1D · May 19, 2025 · DE · Pooled Investment Fund$4.2MView filing →
-
Polis MedTech Ventures LLC - Series 2D · May 19, 2025 · DE · Investing$1.1MView filing →
-
Concierge Pediatrics Holdings, LLCD · Feb 25, 2025 · NY · Other Health Care$5MView filing →